为您找到"
alcon
"相关结果约100,000,000个
Our mission is to provide innovative vision products that enhance quality of life by helping people see better. From vision research to eye health, learn more at Alcon.com.
Alcon is the global leader in innovating life-changing vision products. We help the world see brilliantly, because when people see brilliantly, they live brilliantly. Join us and unleash your full potential. Founded more than 75 years ago, we are the global leader in eye care, with complementary businesses in Surgical, Vision Care, and Ocular ...
Alcon offers a range of products and services for contact lenses, eye care, LASIK and cataract treatment. Whether you need a prescription, relief from allergies, dry eyes or vision enhancement, Alcon can help you see the world clearly.
Alcon is a company that offers eye care solutions for surgical and vision care needs. Learn about its history, products, innovations and social responsibility since 1945.
Alcon is the global leader in eye care, offering a range of products and technologies for vision correction, treatment and management. Learn about Alcon's R&D, pipeline, partnerships, training and education, and stories of innovation.
Alcon is a public company that produces ophthalmic products, such as contact lenses, surgical devices and pharmaceuticals. It was spun off from Novartis in 2019 and has operations in 75 countries and subsidiaries in glaucoma and laser eye surgery.
From surgical innovations to vision products, Alcon helps people see brilliantly. Learn about our company, careers, investor updates, and more.
Alcon offers a range of eye care products for dry eye, eye allergy, and eyelid hygiene. Find solutions for your eye needs and learn more about the #1 selling eye allergy itch relief brand.
Alcon is a global leader in vision and eye care innovation, offering products and services for cataract, refractive, vitreoretinal and contact lens surgery. Explore their latest news, insights, resources and training at MyAlcon.
GENEVA-- (BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the U.S. Food and Drug Administration (FDA) has approved TRYPTYR ® (acoltremon ophthalmic solution) 0.003%, formerly known as AR-15512, for the treatment of signs and symptoms of Dry Eye Disease (DED). 3 TRYPTYR is a first-in-class TRPM8 receptor agonist ...